|
100
|
251
|
3w5qA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
96
|
255
|
3wwrA |
Crystal structure of the human vitamin d receptor ligand binding domain complexed with 1-((((1s,2r,6r,z)-2,6-dihydroxy-4-((e)-2-((1r,3as,7ar)-1-((r)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1h-inden-4(2h)-ylidene)ethylidene)-3-methylenecyclohexyl)oxy)methyl)cyclopropanecarbonitrile |
|
98
|
251
|
3w5pA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
98
|
249
|
3wfgA |
Mineralocorticoid receptor ligand-binding domain with compuond 2e |
|
101
|
255
|
3x36A |
Crystal structure of the human vitamin d receptor ligand binding domain complexed with 7,8-cis-1a,25-dihydroxy-19-norvitamin d3 |
|
96
|
250
|
3wt6A |
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin d receptor: active vitamin d analogues with 22r-alkyl group |
|
98
|
272
|
3wmhA |
Human ppar gamma ligand binding domain in complex with a gammma selective synthetic partial agonist mekt75 |
|
100
|
251
|
3wt5A |
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin d receptor: active vitamin d analogues with 22r-alkyl group |
|
103
|
258
|
3wffA |
Mineralocorticoid receptor ligand-binding domain with compuond 2b |
|
99
|
253
|
3w0iA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
100
|
253
|
3w0gA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
99
|
253
|
3w5rA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
97
|
253
|
3w0cA |
Crystal structure analysis of vitamin d receptor |
|
100
|
253
|
3w5tA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
97
|
253
|
3w0yA |
Crystal structure analysis of vitamin d receptor |
|
98
|
253
|
3w0aA |
Crystal structure analysis of vitamin d receptor |
|
99
|
253
|
3w0jA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
97
|
258
|
3w0hA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
98
|
251
|
3vt4A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
93
|
251
|
3vt9A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
97
|
250
|
3vrwA |
Vdr ligand binding domain in complex with 22s-butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin d3 |
|
96
|
251
|
3vt8A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
95
|
251
|
3vt5A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
103
|
271
|
3vn2A |
Crystal structure of ppargamma complexed with telmisartan |
|
95
|
251
|
3vt7A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
101
|
251
|
3vjtA |
Vitamin d receptor complex with a carborane compound |
|
95
|
274
|
3vjiA |
Human ppar gamma ligand binding domain in complex with jkpl53 |
|
100
|
251
|
3vtcA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin d adtk3 |
|
103
|
274
|
3vspA |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mekt28 |
|
99
|
252
|
3vjsA |
Vitamin d receptor complex with a carborane compound |
|
106
|
260
|
3vhvA |
Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist |
|
100
|
272
|
3vsoA |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mekt21 |
|
98
|
251
|
3vt6A |
Crystal structure of rat vdr-lbd with 2-substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin d3 |
|
99
|
251
|
3vruA |
Vdr ligand binding domain in complex with 2-methylidene-19,24-dinor-1alpha,25-dihydroxy vitamind3 |
|
96
|
274
|
3vjhA |
Human ppar gamma ligand binding domain in complex with jkpl35 |
|
98
|
251
|
3vtbA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin d adtk1 |
|
99
|
250
|
3vrvA |
Vdr ligand binding domain in complex with 2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin d3 |
|
99
|
255
|
3vhuA |
Mineralocorticoid receptor ligand-binding domain with spironolactone |
|
103
|
261
|
3vt3A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
94
|
251
|
3vtdA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin d adtk4 |
|
93
|
249
|
3vrtA |
Vdr ligand binding domain in complex with 2-mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitamind3 |
|
89
|
242
|
3v3qA |
Crystal structure of human nur77 ligand-binding domain in complex with ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate |
|
102
|
267
|
3vi8A |
Human ppar alpha ligand binding domain in complex with a synthetic agonist aphm13 |
|
98
|
249
|
3v49A |
Structure of ar lbd with activator peptide and sarm inhibitor 1 |
|
104
|
271
|
3v9yA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
101
|
255
|
3vhwA |
Crystal structure of the human vitamin d receptor ligand binding domain complexed with 4-mp |
|
87
|
238
|
3v3eA |
Crystal structure of the human nur77 ligand-binding domain |
|
93
|
249
|
3v4aA |
Structure of ar lbd with activator peptide and sarm inhibitor 2 |
|
102
|
271
|
3v9tA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
104
|
271
|
3v9vA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
